摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-chloroethyl)-2-methylimidazole;hydron;chloride

中文名称
——
中文别名
——
英文名称
1-(2-chloroethyl)-2-methylimidazole;hydron;chloride
英文别名
——
1-(2-chloroethyl)-2-methylimidazole;hydron;chloride化学式
CAS
——
化学式
C6H10Cl2N2
mdl
——
分子量
181.06
InChiKey
ANZFVGZRGNLSBV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.85
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    17.8
  • 氢给体数:
    1
  • 氢受体数:
    1

文献信息

  • PHARMACEUTICAL 6,5 HETEROBICYCLIC RING DERIVATIVES
    申请人:UCB Biopharma SPRL
    公开号:EP3527209A1
    公开(公告)日:2019-08-21
    The invention relates to 6,5 heterobicyclic ring derivatives, processes for preparing them, pharmaceutical compositions containing them and their use for the treatment of inflammatory conditions driven by STING activation, such as SLE and geographic atrophy.
    该发明涉及6,5杂环环衍生物,其制备方法,含有它们的药物组合物以及它们用于治疗由STING激活驱动的炎症性疾病,如SLE和地理性萎缩症。
  • Fluorinated ionic liquids with high oxygen solubility for metal-air batteries
    申请人:TOYOTA MOTOR EUROPE
    公开号:US11121422B2
    公开(公告)日:2021-09-14
    Ionic compounds containing an anion, and a cation having the following structural formula (1): R1R2R3N+-(linker1)-O-(linker2)-(FC)  (1) wherein: R1 and R2 either linear or branched alkyl groups or together form a N-heterocylic ring with the nitrogen atom to which they are joined; R3 is linear or branched alkyl group; linker1 and linker2 are alkylene chains or polyether chains; and the group FC is a fluorinated alkyl group, as well as an electrolyte material comprising such an ionic compound and a metal salt, and metal-air batteries using such an electrolyte material. The invention also relates to a metal-air battery containing an electrolyte material, wherein the electrolyte material comprises at least one ionic compound and a metal salt, and wherein at least one ionic compound contains an anion CnF2n+1COO− or CnF2n+1SO3−, where in each case n is at least 1 and at most 10.
    含有一个阴离子和一个阳离子的离子化合物,其结构式如下(1): R1R2R3N+-(linker1)-O-(linker2)-(FC) (1) 其中R1和R2为直链或支链烷基,或与氮原子共同形成N-杂环;R3为直链或支链烷基;连接体1和连接体2为亚烷基链或聚醚链;基团FC为氟化烷基,以及由这种离子化合物和金属盐组成的电解质材料和使用这种电解质材料的金属空气电池。本发明还涉及一种含有电解质材料的金属空气电池,其中电解质材料包含至少一种离子化合物和金属盐,且至少一种离子化合物包含阴离子 CnF2n+1COO- 或 CnF2n+1SO3-,在每种情况下 n 至少为 1,最多为 10。
  • FLUORINATED IONIC LIQUIDS WITH HIGH OXYGEN SOLUBILITY FOR METAL-AIR BATTERIES
    申请人:TOYOTA MOTOR EUROPE
    公开号:US20190190104A1
    公开(公告)日:2019-06-20
    Ionic compounds containing an anion, and a cation having the following structural formula (1): R 1 R 2 R 3 N + -(linker 1 )-O-(linker 2 )-(FC)  (1) wherein: R 1 and R 2 either linear or branched alkyl groups or together form a N-heterocylic ring with the nitrogen atom to which they are joined; R 3 is linear or branched alkyl group; linker 1 and linker 2 are alkylene chains or polyether chains; and the group FC is a fluorinated alkyl group, as well as an electrolyte material comprising such an ionic compound and a metal salt, and metal-air batteries using such an electrolyte material. The invention also relates to a metal-air battery containing an electrolyte material, wherein the electrolyte material comprises at least one ionic compound and a metal salt, and wherein at least one ionic compound contains an anion C n F 2n+1 COO − or C n F 2n+1 SO 3 − , where in each case n is at least 1 and at most 10.
  • Pharmaceutical 6,5 Heterobicyclic Ring Derivatives
    申请人:UCB Biopharma SRL
    公开号:US20200399268A1
    公开(公告)日:2020-12-24
    The invention relates to 6,5 heterobicyclic ring derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use for the treatment of inflammatory conditions driven by STING activation, such as, but not confined to, SLE and geographic atrophy.
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺